The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Covidien head honcho Richard Meelia is leaving his post on the board of Haemonetics Corp. so that he can spend more time with his company.
The Braintree-based blood management company said Meelia is leaving the board “in order to spend more professional time on Covidien’s operations.”
Meelia is leaving two years before his term was set to end in 2011. He joined the board in 2005 and was re-elected in July 2008.
NMT Medical Inc. said it will release data from the clinical trial of its StarFlex implant.
Analysis of data from the study, which aims to determine whether the device can help prevent stroke or ischemia from patent formane ovale, is due to be released during the fourth quarter of 2010. PFO is a defect in the septum separating the heart’s atrial chambers.
The StarFlex implant closes the defect, preventing venous blood from returning to the body without being oxygenated by the lungs.
You are receiving this newsletter because you were part of a group selected to preview www.massdevice.com. The unsubscribe link in our “welcome” newsletter was broken. Please use the following link to unsubscribe if you do not want to receive our newsletters:
We apologize for any inconvenience and thank you for your help and support while we iron out a few last wrinkles before our public launch. Brian Johnson – Publisher, co-founder & Brad Perriello – Executive editor, co-founder
The federal Food & Drug Administration is gearing up to review 25 types of medical devices made before 1976, the year the watchdog agency got its brief to review new medical technologies.
Makers of the devices will have to submit safety and effectiveness data to the FDA within 120 days, which it will use to evaluate the risk level for each device type.
If found to be “of high risk to consumers,” the devices will have to undergo “the agency’s most stringent premarket review process,” according to a press release.
A Missouri-based subsidiary of Mansfield’s Covidien, Mallinckrodt Inc., accused a pair of Italian life science firm Bracco SpA‘s American divisions of patent infringement, The Boston Globe reported.
Hazelwood, Mo.-based Mallinckrodt sued Bracco’s Lake Success, N.Y.-based E-Z-EM Inc. and Acist Medical Systems Inc. of Eden Prairie, Minn., in Delaware federal court for allegedly infringing its patent for a device used to inject chemicals into MRI patients.
By MassDevice
Salaries among top-level executives at Thermo Fisher Scientific rose across the board after the company posted a 31 percent increase to its bottom line.
The Waltham-based laboratory instruments maker said executives received an average base wage increase of about 4 percent in 2008, not including performance bonuses and stock awards.
CEO Marijn Dekkers pulled in the highest compensation, at a $1.1 million base salary and $1.8 million in incentives. He was also granted stock valued at around $15.5 million. Dekkers, 51, took the helm at Thermo Fisher in 2002.
Science fiction is always a few decades ahead of real life — sometimes more.
Remember those giant vegetables in Woody Allen’s 1973 film Sleeper, or the hover skateboard in Back to the Future II, or Mr Spock‘s razor-sharp sideburns in Star Trek?
A press release just came over the transom that reminds me of something I saw in the nearly-straight-to-video masterpiece Idiocracy.
About this company here Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
The National Institutes of Health tapped a prominent Boston-area physician and businessman to sit on a board responsible for setting policy at the federal health research agencies.
James Thrall, radiologist-in-chief at Massachusetts General Hospital, was one of three people named to the board on April 3.
The advisory committee to the director at the NIH is a powerful position. The 20-person board reports directly to the secretary of the federal Health and Human Services Dept., as well as the NIH director on policy matters.
Pharma is sexy. Big drugs, big money, big news. In the life sciences arena, perhaps only biotech commands a higher political and public profile.
So it isn’t surprising that the medical device industry’s groundbreaking inclusion in Massachusetts’ new code of conduct garnered relatively little attention.
But the new rules governing industry payments to physicians — the so-called “gift ban” — include provisions aimed at curbing what some call undue and improper influence by medical device manufacturers.
